Comparing two types of dextrose injections for knee osteoarthritis treatment
Official title: Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Management
Run by Shin Kong Wu Ho-Su Memorial Hospital · NCT06755697 · Data updated 2026-11-12
This study is testing whether a special type of knee injection guided by MRI works better than a standard injection for people aged 45 to 80 with knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Shin Kong Wu Ho-Su Memorial Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | January 23, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2028 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT06755697 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 45 to 80 with knee osteoarthritis who meet specific clinical criteria.
✕Probably not a fit
Patients with severe systemic disorders, recent knee injections, or those who are not suitable for MRI may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of intra-articular versus MRI-guided extra-articular dextrose injections for managing knee osteoarthritis. Participants aged 45 to 80 who meet specific criteria will receive either type of injection to determine which approach yields better outcomes. The study aims to assess the benefits of targeting MRI-positive lesion sites compared to standard intra-articular injections. By utilizing MRI for precise targeting, the researchers hope to enhance treatment efficacy for knee osteoarthritis.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients suffering from knee osteoarthritis.
How similar studies have gone: While there is evidence supporting the use of dextrose injections for knee osteoarthritis, this specific comparison of intra-articular versus MRI-guided extra-articular injections is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. . age between 45 to 80 years old; 2. . meet at least three of the six American College of Rheumatology (ACR) criteria, including age over 50 years, morning stiffness less than 30 minutes, crepitus in passive knee movements, bony tenderness, bony enlargement, and no palpable warmth; 3. . radiologic grading of 2 or 3 according to Kellgren-Lawrence criteria; 4. showing willingness to receive prolotherapy. Exclusion Criteria: 1. . severe systemic disorders including cancer, uncontrolled diabetes mellitus, sepsis, or cardiopulmonary diseases; 2. . history of anticoagulation therapy, knee injection over the past three months; 3. . history of knee surgery or candidates for knee arthroplasty; 4. . history of drug abuse; 5. . a history of intolerance to prolotherapy; 6. . pregnancy; 7. . infectious arthritis, inflammatory joint diseases, joint dysplasia; 8. Body Mass Index (BMI) greater than 35 kg/m2; 9. . not suitable or no willing to received MRI examination of the knee.
Where it's running
-
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Lin-Fen Hsieh — Shin Kong Wu Ho-Su Memorial Hospital
- Study coordinator: Lin-Fen Hsieh
- Email: M001026@ms.skh.org.tw
- Phone: +886-28332211
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Perineural prolotherapy for chronic knee osteoarthritis pain
This trial will test whether adding 5% dextrose to perineural injections reduces pain in adults with chronic knee osteoarthritis.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.